Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Krejczy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.
Biomed Research International|April 9, 2015
Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in GermanyMartin Krejczy, Job Harenberg, Martin Wehling, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|November 9, 2021
Does the Implementation of the PRO-IMPLANT Foundation Treatment Algorithm Improve the Outcome of Chronic Periprosthetic Knee Infections? Mid-Term Results of a Prospective StudyYannik Hanusrichter, Sven Frieler, Jan Gessmann, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.
Biomed Research International|April 9, 2015
Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in GermanyMartin Krejczy, Job Harenberg, Martin Wehling, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|November 9, 2021
Does the Implementation of the PRO-IMPLANT Foundation Treatment Algorithm Improve the Outcome of Chronic Periprosthetic Knee Infections? Mid-Term Results of a Prospective StudyYannik Hanusrichter, Sven Frieler, Jan Gessmann, et al.
Pageof 1